nmCRPC and Survival with Darolutamide
Oncología

Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide

Fizazi K, et al. N Engl J Med. 2020;383:1040-1049.

Related Content
OS and AEs with darolutamide vs apalutamide vs enzalutamide
CPRCnm
Treating the patient and not just the cancer
Cáncer de próstata
Comparison of darolutamide vs apalutamide and enzalutamide
CPRCnm